EcoDrugPlus

Protein Kinase C Theta

Ensembl ID : ENSLOCG00000015666
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSLOCG00000005744
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSLOCG00000010128
Gene Symbol: PRKCHA
1 Cross references
239 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSLOCG00000009700
Gene Symbol: PRKD1
3 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSLOCG00000016864
Gene Symbol: PRKD3
3 Cross references
272 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSLOCG00000006046
Gene Symbol: PRKDC
1 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSLOCG00000011303
Gene Symbol: PPP3CA
4 Cross references
234 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSLOCG00000007702
Gene Symbol: PTK2
1 Cross references
333 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSLOCG00000017241
Gene Symbol: PTK2B
3 Cross references
268 Possible Orthologues:

Protein Tyrosine Kinase 6

Ensembl ID : ENSLOCG00000005191
Gene Symbol: PTK6
3 Cross references
171 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11a

Ensembl ID : ENSLOCG00000007663
Gene Symbol: PTPN11A
1 Cross references
251 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSLOCG00000016219
Gene Symbol: PTPRB
1 Cross references
264 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).